Recurrent rectal cancer: how to predict resectability?

Front Radiat Ther Oncol

Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe University Clinic, Frankfurt am Main, Germany.

Published: November 2004

Download full-text PDF

Source
http://dx.doi.org/10.1159/000078262DOI Listing

Publication Analysis

Top Keywords

recurrent rectal
4
rectal cancer
4
cancer predict
4
predict resectability?
4
recurrent
1
cancer
1
predict
1
resectability?
1

Similar Publications

Ventral Rectopexy: An International Expert Panel Consensus and Review of Contemporary Literature.

Dis Colon Rectum

January 2025

Center for Pelvic Floor Disorders, Department of Surgery, Colorectal Surgery Section, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Background: Ventral rectopexy has become increasingly utilized in the surgical management of rectal prolapse. There is a need for a contemporary evaluation of the role of the procedure and description of its use in clinical practice.

Objective: To create an international consensus on ventral rectopexy.

View Article and Find Full Text PDF

Background: Minimally invasive ventral rectopexy has widely become the preferred prolapse procedure. However there have been recent concerns regarding the safety of permanent synthetic mesh in the pelvis. Biologic grafts have also been commonly used as an alternative prosthesis, but data on their safety and the longevity of the prolapse repair have been lacking.

View Article and Find Full Text PDF

Objectives: This study was conducted to investigate whether preoperative or postoperative carcinoembryonic antigen (CEA) with a new cut-off value is more optimal for predicting long-term outcomes in patients with Stage II/III rectal cancer, and to investigate the effectiveness of postoperative adjuvant chemotherapy (POAC) based on the CEA values.

Methods: Serum CEA levels were measured preoperatively (pre-CEA) and postoperatively (post-CEA). The area under the receiver operating curve (AUROC) was used to determine a cut-off for CEA.

View Article and Find Full Text PDF

Objectives: Differences in oncological outcomes between conservative and surgical treatments for anastomotic leakage (AL) in patients undergoing colorectal cancer surgery remain unclear.

Methods: From July 2011 to June 2020, 385 patients underwent curative resection with double-stapling anastomosis for left-sided colon and rectal cancers. Among them, 33 patients who experienced AL were retrospectively evaluated and categorized into two groups: conservative (n = 20) and surgical (n = 13).

View Article and Find Full Text PDF

Background: Preoperative neoadjuvant chemoradiotherapy (nCRT) is considered to be the standard treatment strategy for locally advanced rectal cancer (LARC); however, the risk of adverse events and postoperative recurrence remains significant. This study aimed to evaluate the non-inferiority of neoadjuvant chemotherapy (nCT) compared with nCRT in patients with LARC and to assess the possibility of eliminating radiotherapy on the basis of guaranteed efficacy.

Materials And Methods: We searched the PubMed, Embase, and Cochrane Library databases to identify randomized controlled trials (RCTs) comparing the efficacy of nCRT and nCT for LARC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!